Banner-dna

New bowel cancer pilot project

Health partnership supports gut health push in Blue Mountains

HOW WE HELPED BUILD AWARENESS OF THE FIRST DNA SCREENS FOR BOWEL CANCER

SHARE THIS CASE STUDY

Australian biotech company Clinical Genomics teamed up with regional insurer, Westfund Health in 2014 to pilot the first commercially available DNA blood that screens for bowel cancer. The new blood test was the result of over a decade of collaborative research between Clinical Genomics, the CSIRO and the Flinders Centre for Innovation in Cancer in Adelaide.

The Blue Mountains played host to the pilot project between July and November 2014. Palin Communications helped coordinate the PR strategy around the roll out and promotion of the pilot.

It saw Lithgow GPs come together for an education that explained the science behind the new test and the logistics for the pilot. Westfund Health provided reimbursements for the either the stool test or the new blood test to members from the Blue Mountains aged 50 or over.

Results

  • Westfund CEO, Grahame Danaher, welcomed the opportunity to become the first person from the Blue Mountains to give a blood sample for the new test and participate in media activity
  • The project was covered on the front page of the Lithgow Mercury
  • Positive editorial stories also appeared in Australian Life Scientist, Medical Observer, Pharma Dispatch and on WIN TV News among others
  • This laid the groundwork for Clinical Genomics to continue discussions about further roll out with key government and patient group stakeholders.
CLICK TO FIND OUT HOW WE CAN HELP YOU

Save Time. Stay updated.